Relay Medical and Swiss PharmaCan AG Appoint Former Nestle Brand Manager and Leafly Marketing Director as Chief Commercial Officer of Glow LifeTech
Toronto, Ontario--(Newsfile Corp. - April 27, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, and Swiss PharmaCan AG, an award-winning European bio-tech company, are pleased to announce the appointment of Marketing Executive Rob Carducci as Chief Commercial Officer (CCO) of Glow LifeTech Ltd. Mr. Carducci's appointment takes effect immediately. Robert Carducci is a seasoned marketing executive with over a decade...
2020-04-27 4:05 PM EDT
Relay Medical Provides Update on the Role of CO-oximetry Technology in Nitric Oxide Therapy for COVID-19
Toronto, Ontario--(Newsfile Corp. - April 22, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on the role of CO-oximetry measurements in nitric oxide therapy which are being investigated to treat COVID-19 patients. Relay is currently developing the HemoPalm-CX, a portable analyzer that provides a full panel of CO-oximetry results including total Hemoglobin (tHb), oxyhemoglobin...
2020-04-22 4:15 PM EDT
Relay Medical and Swiss PharmaCan AG Announce Initial Glow LifeTech Product Line
Toronto, Ontario--(Newsfile Corp. - April 16, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, and Swiss PharmaCan AG, an award-winning European bio-tech company, are pleased to provide an update on the Glow LifeTech ("Glow") Joint-Venture Subsidiary and initial product line. In early March, Relay Medical announced the signing of an agreement whereby Glow LifeTech Ltd. would acquire the exclusive North American...
2020-04-16 4:05 PM EDT
Relay Medical Provides Update on HemoPalm Cybersecurity; Partners with Cybeats Technologies Inc.
Toronto, Ontario--(Newsfile Corp. - April 8, 2020) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on cybersecurity protection on its HemoPalm Corp. devices and the collaboration with world-class cybersecurity company Cybeats Technologies Inc. The HemoPalm device suite is being developed to bring Point-of-Care (POCT) critical diagnostics analyses to the forefront of patient care, which...
2020-04-08 4:05 PM EDT
Relay Medical Announces Completion of Pharmatrac API Development; Now Able to Service Telemedicine Platforms and Medication Management Applications
Toronto, Ontario--(Newsfile Corp. - March 5, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the development of an application programing interface (API) for its Pharmatrac Medication Management System. With this development the Company is now poised for strategic integration with partners in the telemedicine and medication management markets. The Pharmatrac API allows 3rd party mobile...
2020-03-05 4:05 PM EST
Relay Medical Announces Subsidiary Glow LifeTech has Secured Exclusive Rights for Award Winning Swiss Technology for All-Natural Rapid Onset and Enhanced Potency Nutraceutical and Cannabis Products
Toronto, Ontario--(Newsfile Corp. - March 2, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, provides an update on Glow LifeTech Ltd. subsidiary and corporate expansion activities. In December 2018, Relay announced the formation of Glow LifeTech Ltd. ("Glow"), a subsidiary to explore technology opportunities in the global cannabis sector. Relay Medical is pleased to announce that its Glow LifeTech subsidiary has...
2020-03-02 3:00 AM EST
Relay Medical announces Provisional Patent for POCT CO-oximetry Technology; Launches HemoPalm website in Mandarin
Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the filing of a provisional patent entitled Precision Optical Chambers Device, System, and Method of Manufacturing Same, for its HemoPalm-CX Point-of-Care Testing (POCT) CO-Oximetry device. The patent's main claims cover the single-use blood sample cuvette designed to be used with the...
2020-02-27 4:05 PM EST
Relay Medical announces completion of HemoPalm(TM) Proof-of-Principle CO-oximeter Prototype, a Proprietary, State-of-the-Art, Point-of-Care Technology
Toronto, Ontario--(Newsfile Corp. - February 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to announce the completion of the HemoPalm-CX™, a proof-of-principle prototype compact POCT instrument that directly measures five CO-oximetry components from human whole blood. The system uses proprietary optics and data analysis technology developed by the Company's HemoPalm diagnostics division....
2020-02-25 4:05 PM EST
Relay Medical Files Patent on Pharmatrac System Countertop Medication Device
Toronto, Ontario--(Newsfile Corp. - February 20, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the filing of a patent entitled Clustering Station, System, and Method for Alert Scheduling, for its Pharmatrac System. The patent is now pending in 153 countries and regions around the world. The patent's main claims cover the Pharmatrac System's counter-top medication device that has been...
2020-02-20 4:16 PM EST
Relay Medical Presents Pharmatrac Countertop Medication Device; Provides Development Update
Toronto, Ontario--(Newsfile Corp. - February 18, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to provide an update on Pharmatrac development activities and present the Pharmatrac Countertop Medication Device. The Pharmatrac System is being developed to offer sophisticated solutions to improve medication management for patients, caregivers and other stakeholders in the healthcare environment. The...
2020-02-18 4:05 PM EST
Relay Medical Closes $945,000 Debt Financing
Toronto, Ontario--(Newsfile Corp. - January 29, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company completed a financing of $945,000 through the issuance of secured convertible debentures (the "Debentures"). The Debentures will mature on the first anniversary of issuance (the "Maturity Date") and bear interest at a rate of ten percent (10%) per annum which shall accrue from...
2020-01-29 7:58 PM EST
Update: Relay Medical Joint Spectroscopic and Biosensor System for Point-of-Care Testing Patent Granted in China
Toronto, Ontario--(Newsfile Corp. - January 7, 2020) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is pleased to announce an update to September 11th news release regarding the approval for grant of Chinese Patent Application No. 201580025752.6. The company has been informed that the patent has been officially granted by the Chinese patent authority as patent number CN106716137B with an expiry date of May 20, 2035. This new patent continues to expand...
2020-01-07 4:00 PM EST
Relay Medical Announces Extension of Warrant Expiry Date
Toronto, Ontario--(Newsfile Corp. - October 25, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, announces that it intends to extend the expiry date of an aggregate of 7,570,500 previously issued warrants (the "Warrants") at an exercise price of $0.30 for an additional twelve (12) months (the "Amendment"). The exercise price of the Warrants will remain unchanged. About Relay Medical Corp. Relay Medical is an...
2019-10-25 4:39 PM EDT
Relay Medical Announces HemoPalm(TM) Multi-Product Expansion; Formation of HemoPalm Corp. IVD Subsidiary
Toronto, Ontario--(Newsfile Corp. - September 23, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to announce the expansion of the Company's HemoPalm IP into a multi-product family, and formation of the In Vitro Diagnostics (IVD) wholly-owned subsidiary, HemoPalm Corp., part of the Relay Medical Group of Companies. HemoPalm Corp. has been established to accelerate the development and commercialization...
2019-09-23 3:00 AM EDT
Relay Medical Forms Osprey Device Networks Corp. for Point-of-Care Medical Device Fleet and Data Management
Toronto, Ontario--(Newsfile Corp. - September 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the creation of Osprey Device Networks Corp. ("Osprey" or "ODN"), a wholly-owned subsidiary of the Company to commercialize products and services related to the management of decentralized fleets of medical devices and the data streams they produce. On July 2nd, 2019 Relay Medical Corp reported...
2019-09-17 4:19 PM EDT
Relay Medical Joint Spectroscopic and Biosensor System for Point-of-Care Testing Patent Approved for Grant in China
Toronto, Ontario--(Newsfile Corp. - September 12, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine for MedTech innovation, is pleased to announce that it has received formal notice that Patent Application No. 201580025752.6 for Joint Spectroscopic and Biosensor System for Point-of-Care Testing has been approved for grant in China, filed internationally May 20, 2015. Relay Medical's Joint Spectroscopic and Biosensor System for...
2019-09-12 4:06 PM EDT
Relay Medical Announces Closing of Second Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - August 9, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company has completed the second tranche of the private placement financing (the "Offering") for gross proceeds of $542,000 through the issuance of 2,710,000 Units (each, a "Unit") at a price of $0.20 per unit. The aggregate gross proceeds raised pursuant to the first and second tranches...
2019-08-09 5:00 PM EDT
Relay Medical Acquires License to Medical-Grade Cloud Software from Fio Corporation
Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the acquisition of rights to a medical-grade cloud software platform, from Fio Corporation, which develops sophisticated healthcare IT solutions for decentralized and mobile settings across the continuum of care, globally. The software, to be marketed as Relay MedNet, has been acquired to...
2019-07-02 4:30 PM EDT
Relay Medical Develops Pharmatrac Swift, a Plug and Play Solution for Tracking of High Value Medications
Toronto, Ontario--(Newsfile Corp. - June 27, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on extensions to the Pharmatrac platform to address the challenge of tracking expensive medications that are compromised if not properly stored. Highlights: Extended digital medication label design to accommodate blister packs, to broaden the medication packaging form factors with which Pharmatrac is...
2019-06-27 9:44 PM EDT
Relay Medical Appoints Moshe Katzenelson as Senior Vice President, Global Business Development
Toronto, Ontario--(Newsfile Corp. - June 26, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of Moshe Katzenelson as Senior Vice President, Global Business Development. For over 25 years Mr. Katzenelson has played a pivotal role in the advancement of high-tech innovation in Israel's burgeoning technology industry and bringing that innovation to international markets through...
2019-06-26 4:05 PM EDT